The Food and Drug Administration (FDA) has authorized cancer medicines for pancreatic cancer. There are both generic and brand names on the list. This page also includes a list of frequent pancreatic cancer medication combinations. The FDA has authorized the individual medicines in the combinations. However, despite their widespread usage, medication combinations are frequently not authorized.
The medication names take you to the National Cancer Institute’s Cancer Drug Information summary. There may be medicines that are not included here that are used to treat pancreatic cancer.
Drugs Approved for Pancreatic Cancer
- Abraxane (Paclitaxel Albumin-stabilized Nanoparticle Formulation)
- Afinitor (Everolimus)
- Erlotinib Hydrochloride
- Everolimus
- 5-FU (Fluorouracil Injection)
- Fluorouracil Injection
- Gemcitabine Hydrochloride
- Gemzar (Gemcitabine Hydrochloride)
- Infugem (Gemcitabine Hydrochloride)
- Irinotecan Hydrochloride Liposome
- Lynparza (Olaparib)
- Mitomycin
- Olaparib
- Onivyde (Irinotecan Hydrochloride Liposome)
- Paclitaxel Albumin-stabilized Nanoparticle Formulation
- Sunitinib Malate
- Sutent (Sunitinib Malate)
- Tarceva (Erlotinib Hydrochloride)
Drug Combinations Used in Pancreatic Cancer
- FOLFIRINOX
- GEMCITABINE-CISPLATIN
- GEMCITABINE-OXALIPLATIN
- OFF
Drugs Approved for Gastroenteropancreatic Neuroendocrine Tumors
- Afinitor Disperz (Everolimus)
Lanreotide Acetate - Lutathera (Lutetium Lu 177-Dotatate)
- Lutetium Lu 177-Dotatate
- Somatuline Depot (Lanreotide Acetate)
